Rasna Therapeutics Stock Gross Profit
| RASP Stock | USD 0 0.00 0.00% |
Rasna Therapeutics fundamentals help investors to digest information that contributes to Rasna Therapeutics' financial success or failures. It also enables traders to predict the movement of Rasna Pink Sheet. The fundamental analysis module provides a way to measure Rasna Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rasna Therapeutics pink sheet.
Rasna |
Rasna Therapeutics Company Gross Profit Analysis
Rasna Therapeutics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Rasna Therapeutics reported 0.0 of gross profit. This is 100.0% lower than that of the sector and 100.0% lower than that of the Gross Profit industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Rasna Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rasna Therapeutics' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Rasna Therapeutics could also be used in its relative valuation, which is a method of valuing Rasna Therapeutics by comparing valuation metrics of similar companies.Rasna Therapeutics is currently under evaluation in gross profit category among its peers.
Rasna Fundamentals
| Return On Equity | -2.94 | |||
| Return On Asset | -3.7 | |||
| Current Valuation | 1.22 M | |||
| Shares Outstanding | 771.81 M | |||
| Shares Owned By Insiders | 85.10 % | |||
| Price To Book | 0.31 X | |||
| EBITDA | 254.41 K | |||
| Net Income | (686.59 K) | |||
| Cash And Equivalents | 10.52 K | |||
| Total Debt | 91.97 K | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (312.66 K) | |||
| Number Of Employees | 13 | |||
| Beta | -57.77 | |||
| Market Capitalization | 12.04 M | |||
| Total Asset | 85.28 K | |||
| Z Score | 84.6 | |||
| Net Asset | 85.28 K |
About Rasna Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rasna Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rasna Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rasna Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Rasna Pink Sheet Analysis
When running Rasna Therapeutics' price analysis, check to measure Rasna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rasna Therapeutics is operating at the current time. Most of Rasna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rasna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rasna Therapeutics' price. Additionally, you may evaluate how the addition of Rasna Therapeutics to your portfolios can decrease your overall portfolio volatility.